Osteoking prevents bone loss and enhances osteoblastic bone formation by modulating the AGEs/IGF‐1/β‐catenin/OPG pathway in type 2 diabetic <i>db/db</i> miceYi Yang, Hong Zheng, Jintao Li et al.|Cell Biology International|2024Cited by 3
Osteoking Ameliorates Type 2 Diabetes Osteoporosis by Enhancing Osteoblast Differentiation via PI3K/AKT/GSK‐3β Pathway ActivationRong Li, Hong Zheng, Jiangli Lu et al.|Cell Biochemistry and Function|2025Cited by 1